Tag Archives: NJOY

economic development - 8 honored

TGen recognized as ‘2014 Economic Driver’

The Greater Phoenix Chamber of Commerce has selected the Translational Genomics Research Institute (TGen) for one of its 2014 Impact Awards.

TGen was selected among small to medium business in the category of 2014 Economic Driver.

“These companies represent the spirit of the entrepreneur — a spirit that truly makes an impact on our community and our Chamber,” Todd Sanders, GPCC President and CEO, said in a press release. “It’s a privilege to honor those who continue to innovate, take risks, boost our economy and create jobs. Their ability, tenacity and sense of community are an inspiration to all.”

The IMPACT Awards honor the accomplishments of small and large businesses and the impact they have on the Valley’s business community and economy.

“TGen is honored to be recognized by the Greater Phoenix Chamber of Commerce. Through our research into the human genome, we strive to not only make an impact on the Arizona economy, but also endeavor — though precision medicine — to help develop new tools, capabilities and therapies that benefit our patients, and benefit Arizona patients first,” said Tess Burleson, TGen’s Chief Operating Officer.

This year, GPCC recognizes two recipients in each of four categories: Community Champion, Economic Driver, Entrepreneurial Excellence, and Response to Adversity.

Small to Medium Business Category:

2014 Community Champion: Native American Connections

2014 Economic Driver: Translational Genomics Research Institute (TGen)

2014 Entrepreneurial Excellence: Risas Dental and Braces

2014 Response to Adversity: NJOY, Inc.

Large Business Category:

2014 Community Champion: Phoenix Children’s Hospital

2014 Economic Driver: Sundt Construction, Inc.

2014 Entrepreneurial Excellence: The CORE Institute

2014 Response to Adversity: Phoenix Zoo

The 2014 IMPACT Businesses of the Year will be selected from these honorees and announced at the 27th annual IMPACT Awards luncheon, 11:30 a.m.-1:30 p.m. May 15, at the Arizona Biltmore. For more information, visit www.phoenixchamber.com/impact.


NJOY Raises More Than $70 Million

NJOY, the world’s leading independent electronic cigarette company, today announced that it has completed another successful private fundraising round attracting more than $70 million in capital. The round was led by Brookside Capital along with Morgan Stanley Investment Management, investing on behalf of mutual funds and other pooled vehicles for which it acts as investment adviser, GAM Technology Strategy and other institutional investors. The financing will be used to fund the company’s marketing, international expansion and research and development initiatives, including clinical trials.

“As the only electronic cigarette brand whose corporate mission is to obsolete cigarettes, NJOY is dedicated to delivering the most satisfying products to our customers, advancing the science and expanding the brand globally without the inherent conflicts constraining competitors owned by tobacco companies,” said Craig Weiss, CEO of NJOY. “The addition of world-class institutional investors is a reflection of our performance to date, their confidence in NJOY and its growth prospects, and their belief in our mission. The e-cigarette category is robust and competitive, but NJOY’s approach to the market, strong product development pipeline, and thought leadership on key scientific and research issues distinguishes us as the leader they believe is best positioned to ultimately win.”

NJOY is known as an industry pioneer and leader for its product quality, responsible marketing and creative branding, and continues to attract unique strategic investors. In June 2013, the company announced a $75 million funding raise from a group of investors including Sean Parker and Douglas Teitelbaum.